Edition:
India

Second Sight Reports Q3 Non-Gaap Loss Per Share of $0.06

Nov 14 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.06.Q3 SALES $500,000 VERSUS $2.2 MILLION.Q3 NON-GAAP LOSS PER SHARE $0.06 EXCLUDING ITEMS.REACHED AGREEMENT WITH FDA REGARDING PRIMARY EFFICACY ENDPOINT FOR ORION...

Friday, 15 Nov 2019

Axonics Reports Q3 Loss Per Share $0.89

Nov 14 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS AND OPERATIONAL UPDATE.Q3 REVENUE $1.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $1.5 MILLION.QTRLY LOSS PER SHARE $0.89.Q3 EARNINGS PER SHARE VIEW $-0.75 -- REFINITIV IBES DATA.

Friday, 15 Nov 2019

Sedana Medical Adjusts, Clarifies Long-Term Financial Targets

Nov 8 (Reuters) - Sedana Medical AB (publ) ::SEDANA MEDICAL ADJUSTS AND CLARIFIES ITS LONG-TERM FINANCIAL TARGETS.ANNOUNCED THAT COMPANY WILL NO LONGER COMMUNICATE A PROFIT TARGET FOR PERIOD UNTIL REGISTRATION OF ISOCONDA IN EUROPE.SALES TARGET OF SEK 500 MILLION THREE YEARS AFTER EUROPEAN...

Friday, 8 Nov 2019

Expansion & New Markets

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.